[2025-09-25T12:43:08.221444] [QUERYOME] Starting research for query 348: 'Instructions: 
 Answer the question below. Please respond with the option letter (A, B, or C) first. (HINT: Each PubMedQA instance is composed of (1) a question which is either an existing research article title or derived from one, (2) a context which is the corresponding abstract without its conclusion, (3) a long answer, which is the conclusion of the abstract and, presumably, answers the research question, and (4) a yes/no/maybe answer which summarizes the conclusion.) 

Question:
Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer? 

Options:
{'A': 'yes', 'B': 'no', 'C': 'maybe'}'
[2025-09-25T12:43:08.294374] [PI] Starting research for query: 'Instructions: 
 Answer the question below. Please respond with the option letter (A, B, or C) first. (HINT: Each PubMedQA instance is composed of (1) a question which is either an existing research article title or derived from one, (2) a context which is the corresponding abstract without its conclusion, (3) a long answer, which is the conclusion of the abstract and, presumably, answers the research question, and (4) a yes/no/maybe answer which summarizes the conclusion.) 

Question:
Is CA72-4 a useful biomarker in differential diagnosis between ovarian endometrioma and epithelial ovarian cancer? 

Options:
{'A': 'yes', 'B': 'no', 'C': 'maybe'}'
[2025-09-25T12:43:08.296809] Saving text to bench_final/run1/pubmedqa/pubmedqa_347/pi_initial_prompt.txt
[2025-09-25T12:43:08.306522] [PI] Calling o3 for initial analysis...
[2025-09-25T12:43:16.981617] [PI] Reasoning iteration 1
[2025-09-25T12:43:16.983059] [PI reasoning] **Determining CA72-4 use**

I'm analyzing whether CA72-4 is a useful biomarker for differentiating between ovarian endometrioma and epithelial ovarian cancer. Generally, CA72-4 is elevated in ovarian cancer, and it can also show some elevation in endometriomas, but less frequently. The ambiguity of CA125 and CA19-9 adds to the complexity. Studies suggest that CA72-4 is rarely elevated in benign conditions, hinting at a "yes," but we really must lean on the research evidence for a definitive answer. Let's explore this further.
[2025-09-25T12:43:16.985869] [PI] Executing function call 1: hybrid_search
[2025-09-25T12:43:16.987330] [PI] Function arguments: {'query': 'CA72-4 differential diagnosis ovarian endometrioma epithelial ovarian cancer', 'k': 10, 'faiss_weight': 0.6, 'bm25_weight': 0.4, 'use_rrf': True}
[2025-09-25T12:43:16.988915] Saving JSON to bench_final/run1/pubmedqa/pubmedqa_347/pi_iteration_1_tool_call_2_hybrid_search.json
[2025-09-25T12:43:19.662741] [PI] Function hybrid_search executed successfully
[2025-09-25T12:43:19.665788] Saving JSON to bench_final/run1/pubmedqa/pubmedqa_347/pi_iteration_1_tool_result_2_hybrid_search.json
[2025-09-25T12:43:19.672132] [PI] Continuing reasoning with 1 function responses...
[2025-09-25T12:43:28.349504] [PI] Reasoning iteration 2
[2025-09-25T12:43:28.352255] [PI] No function calls found in response
[2025-09-25T12:43:28.354213] [PI] No more function calls - research complete
[2025-09-25T12:43:28.357152] Saving text to bench_final/run1/pubmedqa/pubmedqa_347/pi_final_answer.txt
[2025-09-25T12:43:28.362622] [QUERYOME] Query completed successfully
